Global Drug Discovery Technologies Market

Drug Discovery Technologies Comprehensive Study by Technology (Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, Others), End User (Pharmaceutical Companies, Biopharmaceutical Companies, Biotech Companies, Research Institutes) Players and Region - Global Market Outlook to 2030

Drug Discovery Technologies Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.96%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Drug Discovery Technologies
Drug Discovery refers to identification of new drug for specific diseases. In the recent past, drug discovery was enhanced with emerging technology such as NMR, chemotherapy, mass spectrometry, micro plate readers. Pharmaceuticals and biotech industry collaboration will help to boost global drug discovery technology market. Drug discovery technologies are used for the research as well as launch of new drugs. Rising use of therapeutics in various diseases has created the requirement for drug discovery.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR9.96%


“The FDA’s Center for Drug Evaluation and Research, or CDER, is the specific body within the FDA that is involved with reviewing the new drug development process. The CDER has in-depth understanding of the science used to create new products, testing processes and manufacturing procedures, and the diseases and conditions that are sought to be treated by new products. The CDER provides the scientific and regulatory advice needed to bring new products to market. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Drug Discovery Technologies market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Agilent Technologies, Inc. (United States), Abbott Laboratories, Inc. (United States), GE Healthcare Ltd. (United States), Albany Molecular Research Inc. (United States), Affymetrix Inc. (United States), Arqule Inc. (United States), Luminex Corporation (United States), Bayer Healthcare AG (Germany), Novartis AG (Switzerland), Astrazeneca plc (United Kingdom) and Caliper Life Sciences (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Celera Corp (United States), Charles River Laboratories International (United States), Evotec Ag (Germany) and Thermo Fisher Scientific Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Drug Discovery Technologies market by and Region.



On the basis of geography, the market of Drug Discovery Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Biochips will boost the Drug Discovery Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceutical Companies will boost the Drug Discovery Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancement Using Artificial Intelligence and Pharmaceuticals Enhancement in Various Diseases

Market Growth Drivers:
Rising Number of Chronical Diseases and Technological Enhancement in Molecular Biology, Biotechnology, Genomics and Nanotechnology

Challenges:
Growing Risk of Drug Failure and Lack of Advanced Healthcare Facilities in the Low and Middle Income Group Countries

Restraints:
High Investment in Drug Discovery Technology and Needed Long Time

Opportunities:
Increase Technological Innovation in Drug Discovery Technology and Rising Demand of Small Molecule Drugs for Treating Chronic Diseases

Market Leaders and their expansionary development strategies
In August 2018, Agilent Technologies Inc. has acquired Young In Scientific Co. Ltd. a leading Provider of analytical and scientific instruments in South Korea.
In January 2018, Merck has launched Zinplava (bezlotoxumab) in the United Kingdom. It is new treatment for the deterrence of Clostridium difficile infection (CDI) in adults at high risk for recurrence of CDI.
In United States, According to the FDA, “Accelerated approval is given to some new drugs for serious and life-threatening illnesses that lack satisfactory treatments. This allows an NDA (new drug application) to be approved before measures of effectiveness that would usually be required for approval are available.”

Key Target Audience
Drug Discovery Service Provider, Pharmaceuticals Industries, Medical Research Centre, Medical Institutes, Private Research Agencies, Government Research Agencies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
By Technology
  • Biochips
  • High throughput screening
  • Pharmacogenomics
  • Genomics
  • Bioanalytical instruments
  • Bioinformatics
  • Nanotechnology
  • Others

By End User
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Biotech Companies
  • Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Chronical Diseases
      • 3.2.2. Technological Enhancement in Molecular Biology, Biotechnology, Genomics and Nanotechnology
    • 3.3. Market Challenges
      • 3.3.1. Growing Risk of Drug Failure
      • 3.3.2. Lack of Advanced Healthcare Facilities in the Low and Middle Income Group Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement Using Artificial Intelligence
      • 3.4.2. Pharmaceuticals Enhancement in Various Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Discovery Technologies, by Technology, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Drug Discovery Technologies (Value)
      • 5.2.1. Global Drug Discovery Technologies by: Technology (Value)
        • 5.2.1.1. Biochips
        • 5.2.1.2. High throughput screening
        • 5.2.1.3. Pharmacogenomics
        • 5.2.1.4. Genomics
        • 5.2.1.5. Bioanalytical instruments
        • 5.2.1.6. Bioinformatics
        • 5.2.1.7. Nanotechnology
        • 5.2.1.8. Others
      • 5.2.2. Global Drug Discovery Technologies by: End User (Value)
        • 5.2.2.1. Pharmaceutical Companies
        • 5.2.2.2. Biopharmaceutical Companies
        • 5.2.2.3. Biotech Companies
        • 5.2.2.4. Research Institutes
      • 5.2.3. Global Drug Discovery Technologies Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Drug Discovery Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare Ltd. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Albany Molecular Research Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Affymetrix Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Arqule Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Luminex Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bayer Healthcare AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Astrazeneca plc (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Caliper Life Sciences (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Drug Discovery Technologies Sale, by Technology, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Drug Discovery Technologies (Value)
      • 7.2.1. Global Drug Discovery Technologies by: Technology (Value)
        • 7.2.1.1. Biochips
        • 7.2.1.2. High throughput screening
        • 7.2.1.3. Pharmacogenomics
        • 7.2.1.4. Genomics
        • 7.2.1.5. Bioanalytical instruments
        • 7.2.1.6. Bioinformatics
        • 7.2.1.7. Nanotechnology
        • 7.2.1.8. Others
      • 7.2.2. Global Drug Discovery Technologies by: End User (Value)
        • 7.2.2.1. Pharmaceutical Companies
        • 7.2.2.2. Biopharmaceutical Companies
        • 7.2.2.3. Biotech Companies
        • 7.2.2.4. Research Institutes
      • 7.2.3. Global Drug Discovery Technologies Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Discovery Technologies: by Technology(USD Million)
  • Table 2. Drug Discovery Technologies Biochips , by Region USD Million (2018-2023)
  • Table 3. Drug Discovery Technologies High throughput screening , by Region USD Million (2018-2023)
  • Table 4. Drug Discovery Technologies Pharmacogenomics , by Region USD Million (2018-2023)
  • Table 5. Drug Discovery Technologies Genomics , by Region USD Million (2018-2023)
  • Table 6. Drug Discovery Technologies Bioanalytical instruments , by Region USD Million (2018-2023)
  • Table 7. Drug Discovery Technologies Bioinformatics , by Region USD Million (2018-2023)
  • Table 8. Drug Discovery Technologies Nanotechnology , by Region USD Million (2018-2023)
  • Table 9. Drug Discovery Technologies Others , by Region USD Million (2018-2023)
  • Table 10. Drug Discovery Technologies: by End User(USD Million)
  • Table 11. Drug Discovery Technologies Pharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 12. Drug Discovery Technologies Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 13. Drug Discovery Technologies Biotech Companies , by Region USD Million (2018-2023)
  • Table 14. Drug Discovery Technologies Research Institutes , by Region USD Million (2018-2023)
  • Table 15. South America Drug Discovery Technologies, by Country USD Million (2018-2023)
  • Table 16. South America Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 17. South America Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 18. Brazil Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 19. Brazil Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 20. Argentina Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 21. Argentina Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 22. Rest of South America Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 23. Rest of South America Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 24. Asia Pacific Drug Discovery Technologies, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 26. Asia Pacific Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 27. China Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 28. China Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 29. Japan Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 30. Japan Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 31. India Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 32. India Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 33. South Korea Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 34. South Korea Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 35. Taiwan Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 36. Taiwan Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 37. Australia Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 38. Australia Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 39. Rest of Asia-Pacific Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 40. Rest of Asia-Pacific Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 41. Europe Drug Discovery Technologies, by Country USD Million (2018-2023)
  • Table 42. Europe Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 43. Europe Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 44. Germany Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 45. Germany Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 46. France Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 47. France Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 48. Italy Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 49. Italy Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 50. United Kingdom Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 51. United Kingdom Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 52. Netherlands Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 53. Netherlands Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 54. Rest of Europe Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 55. Rest of Europe Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 56. MEA Drug Discovery Technologies, by Country USD Million (2018-2023)
  • Table 57. MEA Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 58. MEA Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 59. Middle East Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 60. Middle East Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 61. Africa Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 62. Africa Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 63. North America Drug Discovery Technologies, by Country USD Million (2018-2023)
  • Table 64. North America Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 65. North America Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 66. United States Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 67. United States Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 68. Canada Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 69. Canada Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 70. Mexico Drug Discovery Technologies, by Technology USD Million (2018-2023)
  • Table 71. Mexico Drug Discovery Technologies, by End User USD Million (2018-2023)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Drug Discovery Technologies: by Technology(USD Million)
  • Table 84. Drug Discovery Technologies Biochips , by Region USD Million (2025-2030)
  • Table 85. Drug Discovery Technologies High throughput screening , by Region USD Million (2025-2030)
  • Table 86. Drug Discovery Technologies Pharmacogenomics , by Region USD Million (2025-2030)
  • Table 87. Drug Discovery Technologies Genomics , by Region USD Million (2025-2030)
  • Table 88. Drug Discovery Technologies Bioanalytical instruments , by Region USD Million (2025-2030)
  • Table 89. Drug Discovery Technologies Bioinformatics , by Region USD Million (2025-2030)
  • Table 90. Drug Discovery Technologies Nanotechnology , by Region USD Million (2025-2030)
  • Table 91. Drug Discovery Technologies Others , by Region USD Million (2025-2030)
  • Table 92. Drug Discovery Technologies: by End User(USD Million)
  • Table 93. Drug Discovery Technologies Pharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 94. Drug Discovery Technologies Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 95. Drug Discovery Technologies Biotech Companies , by Region USD Million (2025-2030)
  • Table 96. Drug Discovery Technologies Research Institutes , by Region USD Million (2025-2030)
  • Table 97. South America Drug Discovery Technologies, by Country USD Million (2025-2030)
  • Table 98. South America Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 99. South America Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 100. Brazil Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 101. Brazil Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 102. Argentina Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 103. Argentina Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 104. Rest of South America Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 105. Rest of South America Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 106. Asia Pacific Drug Discovery Technologies, by Country USD Million (2025-2030)
  • Table 107. Asia Pacific Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 108. Asia Pacific Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 109. China Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 110. China Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 111. Japan Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 112. Japan Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 113. India Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 114. India Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 115. South Korea Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 116. South Korea Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 117. Taiwan Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 118. Taiwan Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 119. Australia Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 120. Australia Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 121. Rest of Asia-Pacific Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 122. Rest of Asia-Pacific Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 123. Europe Drug Discovery Technologies, by Country USD Million (2025-2030)
  • Table 124. Europe Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 125. Europe Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 126. Germany Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 127. Germany Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 128. France Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 129. France Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 130. Italy Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 131. Italy Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 132. United Kingdom Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 133. United Kingdom Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 134. Netherlands Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 135. Netherlands Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 136. Rest of Europe Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 137. Rest of Europe Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 138. MEA Drug Discovery Technologies, by Country USD Million (2025-2030)
  • Table 139. MEA Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 140. MEA Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 141. Middle East Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 142. Middle East Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 143. Africa Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 144. Africa Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 145. North America Drug Discovery Technologies, by Country USD Million (2025-2030)
  • Table 146. North America Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 147. North America Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 148. United States Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 149. United States Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 150. Canada Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 151. Canada Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 152. Mexico Drug Discovery Technologies, by Technology USD Million (2025-2030)
  • Table 153. Mexico Drug Discovery Technologies, by End User USD Million (2025-2030)
  • Table 154. Research Programs/Design for This Report
  • Table 155. Key Data Information from Secondary Sources
  • Table 156. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Discovery Technologies: by Technology USD Million (2018-2023)
  • Figure 5. Global Drug Discovery Technologies: by End User USD Million (2018-2023)
  • Figure 6. South America Drug Discovery Technologies Share (%), by Country
  • Figure 7. Asia Pacific Drug Discovery Technologies Share (%), by Country
  • Figure 8. Europe Drug Discovery Technologies Share (%), by Country
  • Figure 9. MEA Drug Discovery Technologies Share (%), by Country
  • Figure 10. North America Drug Discovery Technologies Share (%), by Country
  • Figure 11. Global Drug Discovery Technologies share by Players 2023 (%)
  • Figure 12. Global Drug Discovery Technologies share by Players (Top 3) 2023(%)
  • Figure 13. Global Drug Discovery Technologies share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Agilent Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 17. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. GE Healthcare Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 20. GE Healthcare Ltd. (United States) Revenue: by Geography 2023
  • Figure 21. Albany Molecular Research Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Albany Molecular Research Inc. (United States) Revenue: by Geography 2023
  • Figure 23. Affymetrix Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Affymetrix Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Arqule Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Arqule Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Luminex Corporation (United States) Revenue: by Geography 2023
  • Figure 29. Bayer Healthcare AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Bayer Healthcare AG (Germany) Revenue: by Geography 2023
  • Figure 31. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 33. Astrazeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Astrazeneca plc (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Caliper Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 36. Caliper Life Sciences (United States) Revenue: by Geography 2023
  • Figure 37. Global Drug Discovery Technologies: by Technology USD Million (2025-2030)
  • Figure 38. Global Drug Discovery Technologies: by End User USD Million (2025-2030)
  • Figure 39. South America Drug Discovery Technologies Share (%), by Country
  • Figure 40. Asia Pacific Drug Discovery Technologies Share (%), by Country
  • Figure 41. Europe Drug Discovery Technologies Share (%), by Country
  • Figure 42. MEA Drug Discovery Technologies Share (%), by Country
  • Figure 43. North America Drug Discovery Technologies Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Agilent Technologies, Inc. (United States)
  • Abbott Laboratories, Inc. (United States)
  • GE Healthcare Ltd. (United States)
  • Albany Molecular Research Inc. (United States)
  • Affymetrix Inc. (United States)
  • Arqule Inc. (United States)
  • Luminex Corporation (United States)
  • Bayer Healthcare AG (Germany)
  • Novartis AG (Switzerland)
  • Astrazeneca plc (United Kingdom)
  • Caliper Life Sciences (United States)
Additional players considered in the study are as follows:
Celera Corp (United States) , Charles River Laboratories International (United States) , Evotec Ag (Germany) , Thermo Fisher Scientific Inc. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 222 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Discovery Technologies Market Quantitative research analysis
Global Drug Discovery Technologies Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Agilent Technologies, Inc. (United States), Abbott Laboratories, Inc. (United States), GE Healthcare Ltd. (United States), Albany Molecular Research Inc. (United States), Affymetrix Inc. (United States), Arqule Inc. (United States), Luminex Corporation (United States), Bayer Healthcare AG (Germany), Novartis AG (Switzerland), Astrazeneca plc (United Kingdom) and Caliper Life Sciences (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancement Using Artificial Intelligence " is seen as one of major influencing trends for Drug Discovery Technologies Market during projected period 2023-2030.
The Drug Discovery Technologies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Drug Discovery Technologies Market Report?

Have a Query? Click Here

Other Related Reports

Orthodontic Supplies Comprehensive Study by Type (Fixed Braces, Removable Braces, Adhesives), Bracket (Conventional Brackets, Self-ligating Brackets, Lingual Brackets), Material (Metal/Traditional Br...
$ 3450
Pharmacy Retail Comprehensive Study by Type (Generic Drugs, OTC Medicines, Patented Drugs), Product Type (Over the counter Products, Prescription Medical), Channel (Online, Offline), End User (Pharma...
$ 3500
Indocyanine Green Comprehensive Study by Application (Ophthalmology, Neurosurgery, Liver Diseases, Others), Dosage Consideration (Hepatic Impairment, Renal Impairment), End Users (Neonates and Infant...
$ 3650
Drug Delivery Comprehensive Study by Application (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topica...
$ 3750
Nicotine Polacrilex Comprehensive Study by Type (High Purity, Low Purity), Application (Nicotine Polacrilex Gum, Nicotine Polacrilex Lozenge, Other), Distribution Channel (Brick and Mortar Drug Store...
$ 3650
Melanoma Drugs Comprehensive Study by Application (Hospitals, Clinics, Other), Therapy (Chemotherapy, Immuno-therapy, Targeted Therapy, Radiation Therapy) Players and Region - Global Market Outlook t...
$ 3500